Photodynamic therapy: Shedding light on restenosis

Heart

Volumn 86, Issue 6, 2001, Pages 612-618

  Mansfield, R ^a   Bown, S ^b   McEwan, J ^a  

^a MIDDLESEX HOSPITAL   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PHOTOSENSITIZING AGENT;

ARTERY WALL; CORONARY ARTERY OBSTRUCTION; IONIZING RADIATION; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RESTENOSIS; REVIEW; SWINE; TREATMENT OUTCOME;

EID: 0035180530     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/heart.86.6.612     Document Type: Review

References (49)

1. Restenosis after percutaneous transluminal coronary angioplasty (PTCA): A report from the PTCA Registry of the National Heart, Lung, and Blood Institute
2. Restenosis after successful percutaneous transluminal coronary angioplasty: Serial angiographic follow-up of 229 patients
3. Pathoblology of intimal hyperplasia
4. The biology of restenosis
5. Pathophysiology and pharmacological approaches for prevention of coronary artery restenosis following coronary artery balloon angioplasty and related procedures
6. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease
7. Prevention of coronary restenosis: The evolving evidence base for radiation therapy
8. Late coronary occlusion after intracoronary brachytherapy
9. Photody Photodynamic therapy
10. How does photodsmamic therapy work?
11. Release of cytochrome C, Bax migration, Bid cleavage, and activation of caspases 2, 3, 6, 7, 8, and 9 during endothelial cell apoptosis
12. Different effects of photodynamic therapy and gamma-irradiation on vascular smooth muscle cells and matrix: Implications for inhibiting restenosis
13. Photodynamic therapy in the treatment of cancer: Current state of the art
14. Fluorescence of experimental atheromatous plaques with hematoporphyrin derivative
15. Differential modulation of vascular endothelial and smooth muscle cell function by photodynamic therapy of extracellular matrix: Novel insights into radical-mediated prevention of intimal hyperplasia
16. Photodynamic therapy inactivates extracellular matrix-basic fibroblast growth factor: Insights to its effect on the vascular wall
17. Photodynamic therapy inhibits the injury-induced fibrotic response of vascular smooth muscle cells
18. Photodynamic therapy generates a matrix barrier to invasive vascular cell migration
19. Photodynamic therapy of extracellular matrix stimulates endothelial cell growth by inactivation of matrix-associated transforming growth factor-beta
20. Photodynamic therapy of normal rat arteries after photosensitisation using disulphonated aluminium phthalocyanine and 5-aminolaevulinic acid
21. Intraarterial photodynamic therapy using 5-ALA in a swine model
22. Photoangioplasty with local motexafin lutetium delivery reduces macrophages in a rabbit post-balloon injury model
23. Porphyrin and haem biosynthesis and its control
24. Side effects and photosensitization of human tissues after aminolevulinlc acid
25. Comparison of local intravascular drug-delivery catheter systems
26. Local photodynamic therapy with Zn(II)-phthalocyanine in an experimental model of intimal hyperplasia
27. Photodynamic therapy of normal and balloon-injured rat carotid arteries using 5-amino-levulinic acid
28. Photodynamic therapy induces apoptosis in intimal hyperplastic arteries
29. Photodynamic therapy inhibits transforming growth factor beta activity associated with vascular smooth muscle cell injury
30. Photodynamic therapy of arteries. A novel approach for treatment of experimental intimal hyperplasia
31. The effect of photodynamic therapy on the mechanical integrity of normal rabbit carotid arteries
32. Porphyrin accumulation by atheromatous plaques of the aorta
33. In vitro and in vivo uptake of benzoporphyrin derivative into human and miniswine atherosclerotic plaque
34. Delivery of benzoporphyrin derivative, a photosensitizer, into atherosclerotic plaque of Watanabe heritable hyperlipidemic rabbits and balloon-injured New Zealand rabbits
35. Effects of hematoporphyrin derivative and photodynamic therapy on atherosclerotic rabbits
36. Hematoporphyrin uptake in atherosclerotic plaques: Therapeutic potentials
37. Photodynamic therapy for atherosclerotic stenoses in Yucatan miniswine
38. Change in chemical composition of lipids accumulated in atheromas of rabbits following photodynamic therapy
39. Responses of cultured smooth muscle cells from human non-atherosclerotic arteries and primary stenosing lesions after photoradiation: Implications for photodynamic therapy of vascular stenoses
40. Inhibition of intimal hyperplasia by photodynamic therapy using photofrin
41. Photodynamic therapy inhibition of experimental intimal hyperplasia: Acute and chronic effects
42. Inhibition of intimal hyperplasia in balloon-injured arteries with adjunctive phthalocyanine sensitised photodynamic therapy
43. Photodynamic therapy of vein grafts: Suppression of intimal hyperplasia of the vein graft but not the anastomosis
44. Presence of blood significantly decreases transmission of 630 nm laser light
45. Local photodynamic therapy reduces tissue hyperplasia in an experimental restenosis model
46. Reduction in the response to coronary and iliac artery injury with photodynamic therapy using 5-aminolaevulinic acid
47. Intravascular low power red laser light as an adjunct to coronary stent implantation evaluated in a porcine coronary model
48. Clinical study of adjuvant photodynamic therapy to reduce restenosis following femoral angioplasty
49. Photoangioplasty for human peripheral atherosclerosis: Results of a phase I trial of photodynamic therapy with motexafin lutetium (Antrin)